Nanoparticle-Based Antimicrobials: Surface Functionality is Critical [version 1; referees: 2 approved]

Bacterial infections cause 300 million cases of severe illness each year worldwide. Rapidly accelerating drug resistance further exacerbates this threat to human health. While dispersed (planktonic) bacteria represent a therapeutic challenge, bacterial biofilms present major hurdles for both diagnos...

Descrición completa

Detalles Bibliográficos

Principais autores:	Akash Gupta, Ryan F. Landis, Vincent M. Rotello
Formato:	Artigo
Idioma:	Inglês
Publicado:	F1000 Research Ltd 2016-03-01
Series:	F1000Research
Assuntos:	Antimicrobials & Drug Resistance Cellular Microbiology & Pathogenesis Drug Discovery & Design Medical Microbiology Microbial Growth & Development Microbial Physiology & Metabolism Pharmacokinetics & Drug Delivery
Acceso en liña:	http://f1000research.com/articles/5-364/v1
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!